Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC labeling comprehension "real use" data is lacking, NDAC members agree.

This article was originally published in The Tan Sheet

Executive Summary

OTC LABELING COMPREHENSION "REAL USE" DATA IS LACKING, NDAC members agreed at a Sept. 29 meeting on labeling issues. Following a public hearing covering all aspects of OTC label comprehension, from pictograms to type size to order of information, Nonprescription Drugs Advisory Committee member Eric Brass, MD/PhD, Harbor-UCLA Medical Center, remarked that "what is very striking is the lack of comprehensive data on the real use of these drugs...in a truly representative population" and setting.

Topics

UsernamePublicRestriction

Register

PS084378

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel